Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | Undetermined |
| Veröffentlicht: |
München u.a.
Zuckschwerdt
1988
|
| Schlagworte: | |
| Beschreibung: | XXX, 140 S. |
| ISBN: | 3886032515 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV001220698 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 890315s1988 |||| 00||| und d | ||
| 020 | |a 3886032515 |9 3-88603-251-5 | ||
| 035 | |a (OCoLC)630819569 | ||
| 035 | |a (DE-599)BVBBV001220698 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-19 | ||
| 100 | 1 | |a Illiger, Hans J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |c H. J. Illiger ; K. Herdrich |
| 264 | 1 | |a München u.a. |b Zuckschwerdt |c 1988 | |
| 300 | |a XXX, 140 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakokinetik |0 (DE-588)4115557-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Chemotherapeutikum |0 (DE-588)4009895-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Chemotherapeutikum |0 (DE-588)4009895-3 |D s |
| 689 | 0 | 2 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 1 | 2 | |a Pharmakokinetik |0 (DE-588)4115557-9 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 689 | 2 | 0 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |D s |
| 689 | 2 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 2 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 2 | |8 3\p |5 DE-604 | |
| 689 | 3 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 3 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 3 | 2 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |D s |
| 689 | 3 | |8 4\p |5 DE-604 | |
| 689 | 4 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 4 | 1 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |D s |
| 689 | 4 | |8 5\p |5 DE-604 | |
| 700 | 1 | |a Herdrich, Klaus |e Verfasser |4 aut | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000736215 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 5\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804115617097187328 |
|---|---|
| any_adam_object | |
| author | Illiger, Hans J. Herdrich, Klaus |
| author_facet | Illiger, Hans J. Herdrich, Klaus |
| author_role | aut aut |
| author_sort | Illiger, Hans J. |
| author_variant | h j i hj hji k h kh |
| building | Verbundindex |
| bvnumber | BV001220698 |
| ctrlnum | (OCoLC)630819569 (DE-599)BVBBV001220698 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02674nam a2200649 c 4500</leader><controlfield tag="001">BV001220698</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890315s1988 |||| 00||| und d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3886032515</subfield><subfield code="9">3-88603-251-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)630819569</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV001220698</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Illiger, Hans J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen</subfield><subfield code="c">H. J. Illiger ; K. Herdrich</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München u.a.</subfield><subfield code="b">Zuckschwerdt</subfield><subfield code="c">1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXX, 140 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapeutikum</subfield><subfield code="0">(DE-588)4009895-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Chemotherapeutikum</subfield><subfield code="0">(DE-588)4009895-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="8">5\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Herdrich, Klaus</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000736215</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV001220698 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T15:25:27Z |
| institution | BVB |
| isbn | 3886032515 |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000736215 |
| oclc_num | 630819569 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | XXX, 140 S. |
| publishDate | 1988 |
| publishDateSearch | 1988 |
| publishDateSort | 1988 |
| publisher | Zuckschwerdt |
| record_format | marc |
| spelling | Illiger, Hans J. Verfasser aut Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen H. J. Illiger ; K. Herdrich München u.a. Zuckschwerdt 1988 XXX, 140 S. txt rdacontent n rdamedia nc rdacarrier Chemotherapie (DE-588)4127083-6 gnd rswk-swf Pharmakokinetik (DE-588)4115557-9 gnd rswk-swf Chemotherapeutikum (DE-588)4009895-3 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Arzneimittelwechselwirkung (DE-588)4003147-0 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Chemotherapeutikum (DE-588)4009895-3 s Arzneimittelwechselwirkung (DE-588)4003147-0 s 1\p DE-604 Chemotherapie (DE-588)4127083-6 s Pharmakokinetik (DE-588)4115557-9 s 2\p DE-604 Pharmakotherapie (DE-588)4076066-2 s 3\p DE-604 Therapie (DE-588)4059798-2 s 4\p DE-604 Cytostatikum (DE-588)4068347-3 s 5\p DE-604 Herdrich, Klaus Verfasser aut 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 5\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Illiger, Hans J. Herdrich, Klaus Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen Chemotherapie (DE-588)4127083-6 gnd Pharmakokinetik (DE-588)4115557-9 gnd Chemotherapeutikum (DE-588)4009895-3 gnd Cytostatikum (DE-588)4068347-3 gnd Therapie (DE-588)4059798-2 gnd Arzneimittelwechselwirkung (DE-588)4003147-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4127083-6 (DE-588)4115557-9 (DE-588)4009895-3 (DE-588)4068347-3 (DE-588)4059798-2 (DE-588)4003147-0 (DE-588)4076066-2 (DE-588)4073781-0 |
| title | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |
| title_auth | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |
| title_exact_search | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |
| title_full | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen H. J. Illiger ; K. Herdrich |
| title_fullStr | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen H. J. Illiger ; K. Herdrich |
| title_full_unstemmed | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen H. J. Illiger ; K. Herdrich |
| title_short | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |
| title_sort | arzneimittelinteraktionen bei der therapie maligner erkrankungen |
| topic | Chemotherapie (DE-588)4127083-6 gnd Pharmakokinetik (DE-588)4115557-9 gnd Chemotherapeutikum (DE-588)4009895-3 gnd Cytostatikum (DE-588)4068347-3 gnd Therapie (DE-588)4059798-2 gnd Arzneimittelwechselwirkung (DE-588)4003147-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Chemotherapie Pharmakokinetik Chemotherapeutikum Cytostatikum Therapie Arzneimittelwechselwirkung Pharmakotherapie Krebs Medizin |
| work_keys_str_mv | AT illigerhansj arzneimittelinteraktionenbeidertherapiemalignererkrankungen AT herdrichklaus arzneimittelinteraktionenbeidertherapiemalignererkrankungen |